Preoperative Risk Assessment

3

Review clinical trials related to Preoperative Risk Assessment. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

COPD Assessment Test Score and Perioperative Risk in COPD

The goal of this observational cohort study is to evaluate whether the COPD Assessment Test (CAT) score can predict the risk of perioperative respiratory complications in patients aged 40 to 70 years with diagnosed Chronic Obstructive Pulmonary Disease (COPD), undergoing elective surgical procedures lasting no longer than 150 minutes. The main questions it aims to answer are: * Is there a statistically significant association between preoperative CAT scores and the incidence of intraoperative and early postoperative respiratory complications in COPD patients? * Can the CAT score be effectively used as a preoperative risk stratification tool to guide anesthetic and surgical decision-making? Researchers will compare two patient groups based on CAT scores: those with CAT \<10 and those with CAT ≥10 to determine whether higher CAT scores are associated with an increased incidence of perioperative respiratory complications. Participants will: * Complete the CAT questionnaire during the preoperative evaluation * Undergo elective surgery with an expected duration of ≤150 minutes * Be monitored intraoperatively for bronchospasm, oxygen desaturation, and ventilation difficulty * Be monitored postoperatively (within the first 72 hours) for hypoxemia, reintubation, bronchospasm episodes, postoperative pneumonia, intensive care unit (ICU) admission, and length of hospital stay * Have perioperative clinical data collected and analyzed for comparative outcomes between CAT score subgroups

Participants needed: 120
Trial details
Age: 40-70Biological sex: AllType: ObservationalSponsor: Erzurum City HospitalUpdated: Jun 1, 2026Locations: 1Duration: 3 Days
Eligibility criteria

Patients aged between 40 and 70 years [+6]

Patients younger than 40 years or older than 70 years [+7]

Status: Not yet recruiting

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

This is a multicentre, investigator-blinded, randomised controlled trial evaluating whether the use of oral metoclopramide before surgery can reduce the amount of residual gastric content in patients who are taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss. These medications are known to slow down gastric emptying, which may increase the risk of pulmonary aspiration during anaesthesia. Patients will be randomly assigned to either receive metoclopramide 24 hours before surgery or continue with standard care. The primary outcome will be the presence or absence of residual gastric content on ultrasound before surgery. Secondary outcomes include nausea, vomiting, constipation, and any adverse effects of the medication.

Participants needed: 80
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Mater Misericordiae University HospitalUpdated: Aug 6, 2025Locations: 2
Eligibility criteria

Patients taking GLP-1 receptor agonists (for weight loss only) [+4]

Inability to provide informed consent [+9]

Status: Not yet recruiting

Stomach Processing and Emptying Evaluation With Diet and Ultrasound

Gastric content is a key risk factor for aspiration during anesthesia. Although standard fasting times are recommended, various factors-including GLP-1 receptor agonists,-can delay gastric emptying. Gastric ultrasound enables real-time, non-invasive assessment of gastric volume and can help tailor perioperative management. The aim of this study explores the effects of different meal types and physical activity on gastric emptying in healthy individuals.

Participants needed: 60
Trial details
Age: 18-40Biological sex: AllType: InterventionalSponsor: Medical University of WarsawUpdated: May 23, 2025Locations: 1
Eligibility criteria

Age between 18 and 40 years [+4]

Lack of informed consent [+12]